JBIO
NASD Jade Biosciences, Inc.$14.14 ↓ -0.01 (-0.07%) Trading Down from the previous close of $14.15
- YTD change
- -8.36%
- vs 20-day SMA
- -8.01%
- vs 200-day SMA
- -22.66%
Price ranges
Price & Performance
-4.08 (-22.38%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 49.5% away from all-time highs of $28.00
- JBIO is down 8% since the beginning of the year
- JBIO is up 50% over the past 12 months
- JBIO is down 26% over the past 1 month
- 22% of all JBIO investors are betting against JBIO
JBIO reads neutral: price sits below both the 20- and 200-day averages, the 12-month move is +50.5%.
- Previous minute
- +$0.00
- Last hour
- -$0.02
- Last 5 days
- +2.69%
- vs 8-day SMA
- +1.43%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Jade Biosciences, Inc. is a biotechnology company which engages in the development of drugs for rare cardiopulmonary disease. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension. The company was founded by Benjamin T. Dake on July 27, 2018 and is headquartered in Waltham, MA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
